智通财经APP讯,再鼎医药(09688)发布公告,公司根据2024年股权激励计划向40名承授人授出可认购合共20.47万股美国存托股份的购股权,向381名承授人授出涉及合共42.01万股美国存托股份的受限制股份单位,并向4名承授人授出涉及合共3.3万股美国存托股份的业绩股份单位。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.